IP Library Assignment 054150/0011
Patent Assignment
Reel/Frame 054150/0011

Assignment of Assignor's Interest

Recorded: 2020-10-23 Pages: 10
Assignor
ESPERO BIOPHARMA, INC.
Executed: 2020-10-22
Assignee
HESP LLC
312 FARMINGTON AVENUE, FARMINGTON, CONNECTICUT, 06032
Covered Properties (15)
Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
Patent: 6,372,783 →
Application: 09/680,873 →
Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
Patent: 6,362,223 →
Application: 09/684,046 →
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Patent: 6,683,195 →
Application: 10/123,573 →
Publication: US 2002/0193428
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Patent: 6,818,782 →
Application: 10/697,683 →
Publication: US 2004/0097743
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Patent: 6,869,972 →
Application: 10/799,546 →
Publication: US 2004/0176437
Materials and Methods for Treating Coagulation Disorders
Patent: 7,145,020 →
Application: 10/822,129 →
Publication: US 2004/0220258
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Patent: 7,037,933 →
Application: 11/074,152 →
Publication: US 2005/0176805
Materials and Methods for Treating Coagulation Disorders
Patent: 7,253,208 →
Application: 11/101,714 →
Publication: US 2005/0245603
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Patent: 7,105,568 →
Application: 11/101,995 →
Publication: US 2005/0228045
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Patent: 7,351,842 →
Application: 11/423,559 →
Publication: US 2006/0276535
Antiarrhythmic Precursor Compounds, Methods of Synthesis and Methods of Use
Patent: 7,498,449 →
Application: 11/457,719 →
Publication: US 2007/0060640
Materials and Methods for Treating Coagulation Disorders
Patent: 7,285,671 →
Application: 11/467,813 →
Publication: US 2006/0287388
Haloalkyl Ester Derivatives of Coumarin for the Treatment of Coagulation Disorders
Patent: 7,666,902 →
Application: 11/778,482 →
Publication: US 2008/0027132
Halogenated Ester Derivatives of Coumarins for the Treatment of Coagulation Disorders
Patent: 7,932,405 →
Application: 12/268,109 →
Publication: US 2009/0082430
Methods for Treating Atrial Fibrillation
Patent: 9,549,912 →
Application: 13/758,687 →
Publication: US 2013/0143861
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 025006 Frame 0740. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics. the Assignee Name Should Not Have Had Inc. May 31, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028307/0394 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 022529 Frame 0584. Assignor(S) Hereby Confirms the Name of the Assignee to Be Aryx Therapeutics and Not Aryx Therapeutics, Inc.. Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0196 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 023164 Frame 0155. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Aryx Therapeutics and Not Aryx Therapeutics, Inc.. Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0203 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 023164 Frame 0203. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Aryx Therapeutics and Not Aryx Therapeutics Inc. Jun 8, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028349/0801 →
Assignment of Assignor's Interest Jun 8, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 028347/0389 →
Assignment of Assignor's Interest Jun 20, 2012
From: DRUZGALA, PASCAL; ZHANG, XIAOMING; PFISTER, JURG
To: ARYX THERAPEUTICS
Reel/Frame 028411/0068 →
Assignment of Assignor's Interest Oct 1, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029057/0220 →
Assignment of Assignor's Interest Oct 10, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029105/0808 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 016571 Frame 0719. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics Without the Inc. Oct 16, 2012
From: DRUZGALA, PASCAL
To: ARYX THERAPEUTICS
Reel/Frame 029136/0086 →
Change of Name Oct 17, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029148/0007 →
Assignment of Assignor's Interest Oct 22, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029169/0137 →
Correction of Assignors, Peter G. Milner Was Accidently Omitted, When Assignment Previously Recorded at Reel/Frame 029105/0808 Oct 26, 2012
From: DRUZGALA, PASCAL; MILNER, PETER G.
To: ARYX THERAPEUTICS
Reel/Frame 029201/0099 →
Release of Security Interest Feb 6, 2013
From: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029767/0524 →
Security Interest Apr 16, 2019
From: ESPERO BIOPHARMA, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 048918/0544 →
Change of Name Jul 23, 2020
From: ARMETHEON, INC.
To: ESPERO BIOPHARMA, INC.
Reel/Frame 053293/0930 →
Assignment of Assignor's Interest May 4, 2022
From: HESP LLC
To: CADRENAL THERAPEUTICS
Reel/Frame 059811/0221 →
Release of Security Interest Oct 4, 2022
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: ESPERO BIOPHARMA, INC.
Reel/Frame 061299/0927 →
Assignment of Assignor's Interest Jun 4, 2025
From: HESP LLC
To: XYRA, LLC
Reel/Frame 071313/0627 →